John D. Halpern 13D and 13G filings for BROOKLYN IMMUNO THERAPEUTICS L:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-31 07:05 am Purchase |
2023-12-31 | 13G | Eterna Therapeutics Inc. ERNA |
John D. Halpern | 36,726 9.990% |
6,574 (+21.80%) |
Filing |
| 2023-01-31 4:05 pm Purchase |
2023-01-31 | 13G | Eterna Therapeutics Inc. ERNA |
John D. Halpern | 30,152 8.800% |
74 (+0.25%) |
Filing |
| 2022-12-05 5:20 pm Sale |
2022-12-02 | 13G | Eterna Therapeutics Inc. ERNA |
John D. Halpern | 30,078 8.800% |
-286,405 (-90.50%) |
Filing |
| 2021-05-24 1:03 pm Purchase |
2021-03-25 | 13G | Eterna Therapeutics Inc. ERNA |
John D. Halpern | 15,824 11.400% |
15,824 (New Position) |
Filing |